Fibrillary Glomerulonephritis and Multiple Myeloma: A Case Report and Literature Review
Based on our experience, secondary FGN associated with plasma cell neoplasms may represent a rare entity that responds favorably to anti-myeloma therapies. Initial investigations to rule out coexistent plasma cell neoplasms are crucial for the optimal management of FGN patients.
Authors
- Hiroyuki Abé (ORCID: https://orcid.org/0000-0003-4513-1007)
- Kazuki Taoka
- Taiki Ishida
- Masaomi Nangaku (ORCID: https://orcid.org/0000-0001-7401-2934)
- Ken Morita (ORCID: https://orcid.org/0000-0002-6639-5274)
- Yosuke Masamoto (ORCID: https://orcid.org/0000-0002-8168-6459)
- Yosuke Hirakawa (ORCID: https://orcid.org/0000-0001-9238-650X)
- Hideaki Mizuno (ORCID: https://orcid.org/0000-0002-6983-5255)
- Mineo Kurokawa (ORCID: https://orcid.org/0000-0002-4034-2422)
- Motoki Odawara (ORCID: https://orcid.org/0009-0003-8176-6250)
Institutions
- The University of Tokyo (JP)
Publication Details
- Journal
- Case Reports in Oncology
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1159/000545498
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00